Susan K. Rathe

University of Minnesota Medical Center — United States

Medicine · Health Sciences

14h-index820citations95works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(22), Protein Degradation and Inhibitors(21), RNA modifications and cancer(18), Cancer-related molecular mechanisms research(17), Sarcoma Diagnosis and Treatment(11)

Publications95 total

Techniques for Validating CRISPR Changes Using RNA-Sequencing Data
Genes·2025Open Access
DEAPR: Differential Expression and Pathway Ranking Tool Demonstrates NRASG12V and NRASG12D Mutations Have Differing Effects in THP-1 Cells
Cancers·2025· 1 citedOpen Access
Data from Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma
2023Open Access
Data from Proliferation and Self-Renewal Are Differentially Sensitive to <i>NRAS<sup>G12V</sup></i> Oncogene Levels in an Acute Myeloid Leukemia Cell Line
2023· 1 citedOpen Access
Supplemental Figures 1-10 from <i>Sleeping Beauty</i> Screen Identifies <i>RREB1</i> and Other Genetic Drivers in Human B-cell Lymphoma
2023Open Access
Supplementary Data from Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma
2023Open Access
Supplementary Data from Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma
2023Open Access
Data from Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma
2023Open Access
Data from <i>Sleeping Beauty</i> Screen Identifies <i>RREB1</i> and Other Genetic Drivers in Human B-cell Lymphoma
2023Open Access
Supplementary Figure from Proliferation and Self-Renewal Are Differentially Sensitive to <i>NRAS<sup>G12V</sup></i> Oncogene Levels in an Acute Myeloid Leukemia Cell Line
2023Open Access
Supplementary Figure from Proliferation and Self-Renewal Are Differentially Sensitive to <i>NRAS<sup>G12V</sup></i> Oncogene Levels in an Acute Myeloid Leukemia Cell Line
2023Open Access
Data from Proliferation and Self-Renewal Are Differentially Sensitive to <i>NRAS<sup>G12V</sup></i> Oncogene Levels in an Acute Myeloid Leukemia Cell Line
2023Open Access
Table S2 from Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma
2023Open Access
Supplementary Data from Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma
2023Open Access
Data from <i>Sleeping Beauty</i> Screen Identifies <i>RREB1</i> and Other Genetic Drivers in Human B-cell Lymphoma
2023Open Access
Supplementary Data from Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma
2023Open Access
Supplementary Data from Proliferation and Self-Renewal Are Differentially Sensitive to <i>NRAS<sup>G12V</sup></i> Oncogene Levels in an Acute Myeloid Leukemia Cell Line
2023Open Access
Supplemental Figures 1-10 from <i>Sleeping Beauty</i> Screen Identifies <i>RREB1</i> and Other Genetic Drivers in Human B-cell Lymphoma
2023Open Access
Table S2 from Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma
2023Open Access
Supplementary Data from Proliferation and Self-Renewal Are Differentially Sensitive to <i>NRAS<sup>G12V</sup></i> Oncogene Levels in an Acute Myeloid Leukemia Cell Line
2023Open Access
page 1 of 5Next →

Frequent Co-authors

David A. Largaespada(49), Branden S. Moriarity(24), Rebecca S. LaRue(16), Natalie K. Wolf(14), Aaron L. Sarver(12), Eric P. Rahrmann(11), Nuri A. Temiz(11), Milcah C. Scott(10), Jaime F. Modiano(10), Jyotika Varshney(10), Zohar Sachs(10), Anne E. Sarver(9), Timothy D. O’Brien(9), Logan G. Spector(9), Subbaya Subramanian(9), Juan E. Abrahante(8), Zhengming Xiong(6), G. Elizabeth Pluhar(6), Christopher L. Moertel(6), Michael R. Olin(6)